Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
AMPA Receptor - Peptides
Inhibitors |
|
Cat.No. |
Product Name / Activity |
| 1600 | pep2-AVKI |
| Peptide inhibitor of GluR2 subunit binding to PICK1 | |
| 1599 | pep2-EVKI |
| Peptide inhibitor of GluR2 subunit binding to PICK1 | |
| 1595 | pep2m |
| Peptide inhibitor of GluR2 subunit binding to NSF. Reduces AMPA currents | |
| 3801 | Pep2m, myristoylated |
| Myristoylated form of pep2m (Cat. No. 1595). Peptide inhibitor of GluR2 subunit binding to NSF | |
| 1597 | pep2-SVKI |
| Peptide inhibitor of GluR2 subunit binding to GRIP, ABP and PICK1. Increases AMPA current amplitude | |
Other |
|
Cat.No. |
Product Name / Activity |
| 2334 | D15 |
| Endocytosis blocker, impairs AMPA receptor cycling | |
| 1602 | Pep1-AGL |
| GluR1 subunit C-terminus peptide analog. Analog of Pep1-TGL (Cat. No. 1601) | |
| 1601 | Pep1-TGL |
| GluR1 subunit C-terminus peptide analog | |
| 1598 | pep2-SVKE |
| Inactive control peptide for pep2-SVKI (Cat. No. 1597) | |
| 1596 | pep4c |
| Inactive control peptide for pep2m (Cat. No. 1595) | |
Quick Order
Find multiple products by catalog number
Pain Research Product Guide
Highlights over 280 products for Pain research. Request copy or view PDF today.
Calcium Imbalance and Neuroprotective Targets
Written by E. Besancon et al
'Calcium Imbalance and Neuro-protective Targets in Cerebral Ischemia & Brain Injury' highlights the key targets involved in stroke, trauma and neurodegeneration.
Neurobiology of Parkinson's Disease
Written by A. Schapira
'Neurobiology and Therapeutics of Parkinson's Disease' highlights the neurobiology of Parkinson's disease and summarizes current and novel therapeutic interventions.
Antidepressants - Current and Future Targets
Written by P. Skolnich et al
'Antidepressants - Current and Future Targets' provides an overview of the current and future targets for the treatment of major depressive disorder.
Therapeutic Strategies in Schizophrenia
Written by J. Lieberman
'Schizophrenia - Emerging Targets and Therapeutic Strategies' provides a summary of the targets and pathways representing the most promising strategies to pursue for novel drug development.
The Neurobiology of Alzheimer's Disease
Written by Alan Palmer
'The Neurobiology of Alzheimer's Disease' summarizes structural and functional changes observed in the progression of AD.
Tocris Events
Win a Kindle
June 21, 2013
London, UK